Literature DB >> 34290961

Nosocomial mucormycosis of the thigh.

Carl Boodman1, Matthew P Cheng2.   

Abstract

We describe a case of nosocomial mucormycosis of the thigh in an immunocompromised patient admitted with COVID-19 acute respiratory distress syndrome.
© 2021 The Authors.

Entities:  

Keywords:  COVID-19; Cutaneous; Fungi; Immunocompromised; Mucormycosis; musculoskeletal

Year:  2021        PMID: 34290961      PMCID: PMC8272011          DOI: 10.1016/j.idcr.2021.e01225

Source DB:  PubMed          Journal:  IDCases        ISSN: 2214-2509


A necrotic skin lesion developed in a 54-year-old man admitted to the intensive care unit with acute respiratory distress syndrome (ARDS) caused by COVID-19. The lesion occurred at the site of a thigh hematoma caused by arterial line insertion one month earlier. The patient was known for diffuse large B-cell lymphoma and had received chimeric antigen receptor T cells 7 months prior to presentation. He was receiving dexamethasone and was on veno-venous extracorporeal membrane oxygenation (ECMO) for COVID-19 ARDS. Physical examination demonstrated a 23.5-centimeter x 13-centimeter necrotic eschar superimposed by white mycelium (Fig. 1). Culture of the mycelium grew Rhizopus species, within the Mucorales fungal order. The patient was started on amphotericin B deoxycholate and posaconazole and taken urgently to the operating room for debridement. Intraoperative assessment demonstrated deep fungal tissue invasion (Fig. 2). The patient died 24 h after surgery.
Fig. 1

Necrotic eschar of the thigh with arrow demonstrating white mycelium.

Fig. 2

Deep debridement was necessary to remove infected necrotic tissue.

Necrotic eschar of the thigh with arrow demonstrating white mycelium. Deep debridement was necessary to remove infected necrotic tissue.

Source of funding

No sources of funding.

Ethical approval

N/A.

Consent

Patient consent was obtained.

Author contribution

MC was responsible for the conceptualization of the piece and taking the photos and editing the manuscript. CB wrote the initial manuscript. Both authors cared for the patient in question.

Author statement

No funding of any kind was received by any of the authors for this project. The authors have no competing interests or financial interests in this article. There are no academic commitments, personal relationships, political/religious beliefs or institutional affiliations that interfere with the publication of this paper. Consent was obtained for the publication of this case.

Declaration of Competing Interest

The authors report no declarations of interest.
  1 in total

1.  Successful treatment of pulmonary mucormycosis (Lichtheimia spp.) in a post-partum patient with COVID-19 ARDS requiring extra-corporeal membrane oxygenation using salvage therapy.

Authors:  Justin Hanks; Shinya Unai; Alejandro Bribriesco; Steven Insler; Eileen Yu; Jona Banzon; Eduardo Mireles-Cabodevila; Ahmad Adi; Haytham Elgharably; James Yun; Sudhir Krishnan
Journal:  Perfusion       Date:  2022-08-17       Impact factor: 1.581

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.